PEPTHEMATICS

| Written by Kevin Facun

Peptides and Modified Blood Products for Diagnosis and Treatment of Coagulopathic, Inflammatory and Infectious Conditions

 

INVENTORS:

Dr. Salvador Eugenio C. Caoili, Dr. Ruby Anne N. King, Dr. Fresthel Monica M. Climacosa, Dr. Bobbie Marie M. Santos

 

DESCRIPTION

The invention provides peptide derivatives and modified blood products for evaluating and modulating blood plasma coagulation activity, complement function, and infection-related processes.

 

VALUE PROPOSITION

  • New materials for diagnostics
  • Alternatives to conventional therapies
  • Repurposing of medical waste

 

MARKET APPLICATIONS AND COMMERCIAL OPPORTUNITIES

Probing and/or modulating biochemical mechanisms relating to processes of blood coagulation and humoral immunity.

 

DEVELOPMENT STATUS

The technology is currently under laboratory testing and needs further research and development.

 

IP STATUS

Patent Application Filed

Application No. 1-2018-050480

 

TYPE OF PARTNERSHIP BEING SOUGHT

Licensing. Looking for partners or collaborators for clinical validation trials, licensees.